MedTrace Logo

High Flow Nasal Therapy Versus Noninvasive Ventilation in COPD Exacerbation

NCT03370666 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-04-30

No results posted yet for this study

Summary

Randomized multicenter non-inferiority trial comparing High flow nasal therapy (HFNT) versus Noninvasive ventilation (NIV) in patients with chronic obstructive pulmonary disease (COPD) and acute hypercapnic respiratory failure.

Conditions

  • COPD Exacerbation

Interventions

OTHER

HFNT

High flow nasal therapy

OTHER

NIV

Noninvasive ventilation

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Mater Domini, Catanzaro

    collaborator OTHER

  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

    lead OTHER

Principal Investigators

  • Paolo Navalesi, MD · Azienda Ospedaliera Universitaria Mater Domini, Catanzaro

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2020-03-25
Completion
2020-04-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03370666 on ClinicalTrials.gov